EuroBiOpartnering will be taking place during the three days of EuroBiO. This international business convention is designed for start-ups and other small & medium-sized businesses as well as multinationals from the biotech, pharmaceutical, diagnostics, agrifood and environmental sectors, as well as investors and banks, private and public-sector research organizations or public institutions and local authorities.
Its objectives are to enable participants to contact and forge links with their future partners, obtain finance, and identify innovative projects. It also aims at boosting interest from international investors in biotechnology companies based in the Paris Region and throughout France and at encouraging new entities to relocate here.
A web portal (EuroBiOpartnering) is entirely dedicated to the business convention. It allows the participants, before the start of EuroBiO 2008, to introduce their companies and present their offers and requests, to identify the profiles which match their requirements, and to plan one-to-one interviews and meetings, which will take place at the EuroBiO. The website gives access to the three types of partnerting:
- Business-to-Business;
- Business-to-Technology;
- Research Funds-to-Business.
Business‐to‐business
Business-to-business partnering is the core strand of EuroBiO 2008 and brings together
European, US and Asian companies. The B to B facilitates contact between future commercial
collaborators, or development partners.
Business‐to‐Technology
Registration enables companies to find institutions and technology transfer organisations with a
huge range of projects for licensing, acquisition, or collaboration.
Research Funds-to-Business
Awarded EU label and starting with the EU's massive Framework 7 Program sympathetic to the
administrative needs of small-to-medium-sized businesses, EuroBiO offers a direct connection
to R&D funding at a European and national level. Registration enables companies to identify
projects in preclinical development, orphan diseases, neurobiology they wish to lead or
participate in.
For further information, please visit:
http://www.eurobio2008.com
Related news articles:
About EuroBiO
Founded in 1997 on the initiative of the French Ministry of Research, the then called European Biotech Crossroads has rapidly succeeded in bringing together all the biotechnology actors and stakeholders: life science companies, start‐up projects, students, researchers, private & public‐sector research organizations, industry bodies, investors, consulting firms, multinationals from the biotech,
pharmaceutical, diagnostics, agrifood & environmental sectors, local authorities, clusters, bioparks,
bioincubators, public authorities and regulatory bodies.
In 2006, the European Biotech Crossroads took place in Paris for its 10th anniversary. Under the guidance of Eric Poincelet, former Director General of The World Life Sciences Forum BioVision and founder of BioSquare, the Event was totally transformed on this occasion and remodelled according to the US BIO structure: Four Pillars, Three Sectors, and Three Generations. To reflect this transformation into what is set to become "The European BIO", the name EuroBiO was adopted. Over 4,000 experts already joined in the newly "revamped" EuroBiO in 2006. And over 5,000 are expected for this EU Presidency Edition 2008.
EuroBiO is now a truly international event, with a prime focus on European issues. The Event is dedicated to Life Sciences in general - and in particular, to biotech's three major fields of application - Health, Environment and Agro‐industry.
The overall setting of EuroBiO 2008 was awarded to Paris and Region Ile‐de‐France; the concrete organization of the event is ensured by its Regional Economic Development Agency for Paris Ile-de-France (ARD) and its Partner, Package Organization.